Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients

Clinical trial NCT07338344 · RECRUITING

Trial details

NCT number: NCT07338344
Sponsor: Rongrong Liu
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Transfusion-dependent β-thalassemia Patients

Start date: 2026-02-01
Primary completion: 2027-12-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.